ANEB - Anebulo Pharmaceuticals GAAP EPS of -$0.05 February, 11 2022 09:04 AM Anebulo Pharmaceuticals Inc. Anebulo Pharmaceuticals press release (NASDAQ:ANEB): Q2 GAAP EPS of -$0.05. Cash and cash equivalents were $18M as of December 31, 2021 For further details see: Anebulo Pharmaceuticals GAAP EPS of -$0.05